Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion.
Increasing consumption of alcohol and sedentary lifestyle are likely to boost the growth of colorectal cancer over the forecast period.
Market Analysis and Insights: Global Carcinoembryonic Antigen (CEA) Market
The global Carcinoembryonic Antigen (CEA) market size is projected to reach US$ 1831.1 million by 2026, from US$ 1753.7 million in 2020, at a CAGR of 4.1%% during 2021-2026.
Global Carcinoembryonic Antigen (CEA) Scope and Market Size
Carcinoembryonic Antigen (CEA) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Carcinoembryonic Antigen (CEA) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Roche Diagnostics
Abbott Diagnostics
Quest Diagnostics
...
Carcinoembryonic Antigen (CEA) Breakdown Data by Type
CD66a
CD66b
CD66c
CD66d
CD66e
CD66f
Carcinoembryonic Antigen (CEA) Breakdown Data by Application
Colorectal Cancer
Pancreatic Cancer
Ovarian Cancer
Breast Cancer
Thyroid Cancer
Others
Increasing consumption of alcohol and sedentary lifestyle are likely to boost the growth of colorectal cancer over the forecast period.
Market Analysis and Insights: Global Carcinoembryonic Antigen (CEA) Market
The global Carcinoembryonic Antigen (CEA) market size is projected to reach US$ 1831.1 million by 2026, from US$ 1753.7 million in 2020, at a CAGR of 4.1%% during 2021-2026.
Global Carcinoembryonic Antigen (CEA) Scope and Market Size
Carcinoembryonic Antigen (CEA) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Carcinoembryonic Antigen (CEA) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Roche Diagnostics
Abbott Diagnostics
Quest Diagnostics
...
Carcinoembryonic Antigen (CEA) Breakdown Data by Type
CD66a
CD66b
CD66c
CD66d
CD66e
CD66f
Carcinoembryonic Antigen (CEA) Breakdown Data by Application
Colorectal Cancer
Pancreatic Cancer
Ovarian Cancer
Breast Cancer
Thyroid Cancer
Others
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Carcinoembryonic Antigen (CEA) Revenue
1.4 Market by Type
1.4.1 Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 CD66a
1.4.3 CD66b
1.4.4 CD66c
1.4.5 CD66d
1.4.6 CD66e
1.4.7 CD66f
1.5 Market by Application
1.5.1 Global Carcinoembryonic Antigen (CEA) Market Share by Application: 2020 VS 2026
1.5.2 Colorectal Cancer
1.5.3 Pancreatic Cancer
1.5.4 Ovarian Cancer
1.5.5 Breast Cancer
1.5.6 Thyroid Cancer
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Carcinoembryonic Antigen (CEA) Market Perspective (2015-2026)
2.2 Global Carcinoembryonic Antigen (CEA) Growth Trends by Regions
2.2.1 Carcinoembryonic Antigen (CEA) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Carcinoembryonic Antigen (CEA) Historic Market Share by Regions (2015-2020)
2.2.3 Carcinoembryonic Antigen (CEA) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Carcinoembryonic Antigen (CEA) Market Growth Strategy
2.3.6 Primary Interviews with Key Carcinoembryonic Antigen (CEA) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Carcinoembryonic Antigen (CEA) Players by Market Size
3.1.1 Global Top Carcinoembryonic Antigen (CEA) Players by Revenue (2015-2020)
3.1.2 Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Players (2015-2020)
3.1.3 Global Carcinoembryonic Antigen (CEA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio
3.2.1 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Carcinoembryonic Antigen (CEA) Revenue in 2019
3.3 Carcinoembryonic Antigen (CEA) Key Players Head office and Area Served
3.4 Key Players Carcinoembryonic Antigen (CEA) Product Solution and Service
3.5 Date of Enter into Carcinoembryonic Antigen (CEA) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Carcinoembryonic Antigen (CEA) Historic Market Size by Type (2015-2020)
4.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
5.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
6.2 Carcinoembryonic Antigen (CEA) Key Players in North America (2019-2020)
6.3 North America Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
6.4 North America Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
7.2 Carcinoembryonic Antigen (CEA) Key Players in Europe (2019-2020)
7.3 Europe Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
7.4 Europe Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
8 China
8.1 China Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
8.2 Carcinoembryonic Antigen (CEA) Key Players in China (2019-2020)
8.3 China Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
8.4 China Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
9.2 Carcinoembryonic Antigen (CEA) Key Players in Japan (2019-2020)
9.3 Japan Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
9.4 Japan Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
10.2 Carcinoembryonic Antigen (CEA) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
10.4 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
11 India
11.1 India Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
11.2 Carcinoembryonic Antigen (CEA) Key Players in India (2019-2020)
11.3 India Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
11.4 India Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
12.2 Carcinoembryonic Antigen (CEA) Key Players in Central & South America (2019-2020)
12.3 Central & South America Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
12.4 Central & South America Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Details
13.1.2 Roche Diagnostics Business Overview
13.1.3 Roche Diagnostics Carcinoembryonic Antigen (CEA) Introduction
13.1.4 Roche Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020))
13.1.5 Roche Diagnostics Recent Development
13.2 Abbott Diagnostics
13.2.1 Abbott Diagnostics Company Details
13.2.2 Abbott Diagnostics Business Overview
13.2.3 Abbott Diagnostics Carcinoembryonic Antigen (CEA) Introduction
13.2.4 Abbott Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020)
13.2.5 Abbott Diagnostics Recent Development
13.3 Quest Diagnostics
13.3.1 Quest Diagnostics Company Details
13.3.2 Quest Diagnostics Business Overview
13.3.3 Quest Diagnostics Carcinoembryonic Antigen (CEA) Introduction
13.3.4 Quest Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020)
13.3.5 Quest Diagnostics Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Carcinoembryonic Antigen (CEA) Revenue
1.4 Market by Type
1.4.1 Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 CD66a
1.4.3 CD66b
1.4.4 CD66c
1.4.5 CD66d
1.4.6 CD66e
1.4.7 CD66f
1.5 Market by Application
1.5.1 Global Carcinoembryonic Antigen (CEA) Market Share by Application: 2020 VS 2026
1.5.2 Colorectal Cancer
1.5.3 Pancreatic Cancer
1.5.4 Ovarian Cancer
1.5.5 Breast Cancer
1.5.6 Thyroid Cancer
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Carcinoembryonic Antigen (CEA) Market Perspective (2015-2026)
2.2 Global Carcinoembryonic Antigen (CEA) Growth Trends by Regions
2.2.1 Carcinoembryonic Antigen (CEA) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Carcinoembryonic Antigen (CEA) Historic Market Share by Regions (2015-2020)
2.2.3 Carcinoembryonic Antigen (CEA) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Carcinoembryonic Antigen (CEA) Market Growth Strategy
2.3.6 Primary Interviews with Key Carcinoembryonic Antigen (CEA) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Carcinoembryonic Antigen (CEA) Players by Market Size
3.1.1 Global Top Carcinoembryonic Antigen (CEA) Players by Revenue (2015-2020)
3.1.2 Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Players (2015-2020)
3.1.3 Global Carcinoembryonic Antigen (CEA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio
3.2.1 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Carcinoembryonic Antigen (CEA) Revenue in 2019
3.3 Carcinoembryonic Antigen (CEA) Key Players Head office and Area Served
3.4 Key Players Carcinoembryonic Antigen (CEA) Product Solution and Service
3.5 Date of Enter into Carcinoembryonic Antigen (CEA) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Carcinoembryonic Antigen (CEA) Historic Market Size by Type (2015-2020)
4.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
5.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
6.2 Carcinoembryonic Antigen (CEA) Key Players in North America (2019-2020)
6.3 North America Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
6.4 North America Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
7.2 Carcinoembryonic Antigen (CEA) Key Players in Europe (2019-2020)
7.3 Europe Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
7.4 Europe Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
8 China
8.1 China Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
8.2 Carcinoembryonic Antigen (CEA) Key Players in China (2019-2020)
8.3 China Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
8.4 China Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
9.2 Carcinoembryonic Antigen (CEA) Key Players in Japan (2019-2020)
9.3 Japan Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
9.4 Japan Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
10.2 Carcinoembryonic Antigen (CEA) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
10.4 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
11 India
11.1 India Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
11.2 Carcinoembryonic Antigen (CEA) Key Players in India (2019-2020)
11.3 India Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
11.4 India Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
12.2 Carcinoembryonic Antigen (CEA) Key Players in Central & South America (2019-2020)
12.3 Central & South America Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
12.4 Central & South America Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Details
13.1.2 Roche Diagnostics Business Overview
13.1.3 Roche Diagnostics Carcinoembryonic Antigen (CEA) Introduction
13.1.4 Roche Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020))
13.1.5 Roche Diagnostics Recent Development
13.2 Abbott Diagnostics
13.2.1 Abbott Diagnostics Company Details
13.2.2 Abbott Diagnostics Business Overview
13.2.3 Abbott Diagnostics Carcinoembryonic Antigen (CEA) Introduction
13.2.4 Abbott Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020)
13.2.5 Abbott Diagnostics Recent Development
13.3 Quest Diagnostics
13.3.1 Quest Diagnostics Company Details
13.3.2 Quest Diagnostics Business Overview
13.3.3 Quest Diagnostics Carcinoembryonic Antigen (CEA) Introduction
13.3.4 Quest Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020)
13.3.5 Quest Diagnostics Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
